Press Releases

11/29/2018

New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients

continue →

Topics: CELLSEARCH, CTCs, Precision Medicine, metastatic breast cancer, Liquid biopsy

03/12/2018

A robust method to study cancer heterogeneity in liquid biopsy

Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy

continue →

Topics: Liquid biopsy, CTCs, Precision Medicine, low-pass, copy number alteration, CELLSEARCH, DEPArray NxT, NGS

04/3/2017

Menarini-Silicon Biosystems Completes Acquisition of CELLSEARCH® Assets

Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market

continue →

Topics: CELLSEARCH, acquisition, CTC test, CTCs, Liquid biopsy, deparray

12/20/2016

Menarini-Silicon Biosystems to Acquire CELLSEARCH® CTC System

Only FDA-Cleared CTC test to join Company’s Portfolio of Diagnostics

continue →

Topics: CTCs, CELLSEARCH, deparray, single-cell isolation

Ask Us a QuestionShare your DEPArray™ storySubscribe to newsletter